scorecardresearch
Friday, August 1, 2025
TopicAstraZeneca

Topic: AstraZeneca

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

AstraZeneca withdraws Covid vaccine worldwide, cites commercial reasons

Firm says vaccine has been superseded by updated ones that fight new variants & is no longer being made, supplied. Earlier, it had said its vaccine can cause a rare, dangerous side effect.

How safe is AstraZeneca Covid vaccine & why there is no need to panic — some key questions answered

51 cases have been lodged in a UK court against biopharma company over claims that its Covid vaccine caused death and injury in several cases.

Modi photo missing from Covid vaccine certificates due to model code, say health ministry officials

Prime Minister Narendra Modi’s photo was also removed from Covid-19 vaccination certificates issued in 5 poll-bound states in 2022 at EC's directions.

Don’t let anti-vaxxers weaponise AstraZeneca furore. Vaccines are safe—and we are the proof

Vaccines have eliminated two diseases—smallpox in humans and rinderpest in cattle. If they were killing one in 50,000 people, we wouldn’t be rolling them out across the globe for decades.

AstraZeneca vaccine safe, effective in kids, finds Lancet study. WHO still says for adults only

The vaccine, marketed as Covishield in India, induced antibody concentrations in children similar to those associated with high efficacy in adults, says study by UK researchers.

Covishield shows increased antibody response to Omicron after 3rd dose: AstraZeneca

Preliminary data released by AstraZeneca shows Vaxzevaria vaccine, administered in India as Covishield, increased immune response to Beta, Delta, Alpha, Gamma variants after third dose.

AstraZeneca’s antibody cocktail gets US nod for Covid prevention in those with low immunity

According to company Evusheld 'neutralises all previous SARs-CoV-2 variants to date'. AstraZeneca now intends to apply for approval in India.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

AstraZeneca vaccine has no adverse impact on pregnancy or fertility, study in Lancet says

In the study spanning UK, Brazil and South Africa, the rate of miscarriage was roughly the same between vaccine and placebo groups, & no still births or neonatal deaths were recorded.

On Camera

Trump tariff forces India to shed illusion. Stop conflating status with power

India’s future lies in pragmatism. Protectionism must be phased out gradually, not in disruptive shocks.

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.